AshleyBanksNIHR commited on
Commit
a90c70e
·
verified ·
1 Parent(s): d09fefc

Upload 7 files

Browse files
config.json ADDED
@@ -0,0 +1,128 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ {
2
+ "architectures": [
3
+ "BertForSequenceClassification"
4
+ ],
5
+ "attention_probs_dropout_prob": 0.1,
6
+ "bos_token_id": 0,
7
+ "classifier_dropout": null,
8
+ "dtype": "float32",
9
+ "eos_token_ids": 0,
10
+ "hidden_act": "gelu",
11
+ "hidden_dropout_prob": 0.1,
12
+ "hidden_size": 1024,
13
+ "id2label": {
14
+ "0": "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING",
15
+ "1": "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES",
16
+ "2": "1.3 CHEMICAL AND PHYSICAL SCIENCES",
17
+ "3": "1.4 METHODOLOGIES AND MEASUREMENTS",
18
+ "4": "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)",
19
+ "5": "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS",
20
+ "6": "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT",
21
+ "7": "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS",
22
+ "8": "2.4 SURVEILLANCE AND DISTRIBUTION",
23
+ "9": "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)",
24
+ "10": "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)",
25
+ "11": "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING",
26
+ "12": "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS",
27
+ "13": "3.3 NUTRITION AND CHEMOPREVENTION",
28
+ "14": "3.4 VACCINES",
29
+ "15": "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)",
30
+ "16": "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES",
31
+ "17": "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES",
32
+ "18": "4.3 INFLUENCES AND IMPACT",
33
+ "19": "4.4 POPULATION SCREENING",
34
+ "20": "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)",
35
+ "21": "5.1 PHARMACEUTICALS",
36
+ "22": "5.2 CELLULAR AND GENE THERAPIES",
37
+ "23": "5.3 MEDICAL DEVICES",
38
+ "24": "5.4 SURGERY",
39
+ "25": "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
40
+ "26": "5.6 PSYCHOLOGICAL AND BEHAVIOURAL",
41
+ "27": "5.7 PHYSICAL",
42
+ "28": "5.8 COMPLEMENTARY",
43
+ "29": "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)",
44
+ "30": "6.1 PHARMACEUTICALS",
45
+ "31": "6.2 CELLULAR AND GENE THERAPIES",
46
+ "32": "6.3 MEDICAL DEVICES",
47
+ "33": "6.4 SURGERY",
48
+ "34": "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
49
+ "35": "6.6 PSYCHOLOGICAL AND BEHAVIOURAL",
50
+ "36": "6.7 PHYSICAL",
51
+ "37": "6.8 COMPLEMENTARY",
52
+ "38": "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)",
53
+ "39": "7.1 INDIVIDUAL CARE NEEDS",
54
+ "40": "7.2 END OF LIFE CARE",
55
+ "41": "7.3 MANAGEMENT AND DECISION MAKING",
56
+ "42": "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)",
57
+ "43": "8.1 ORGANISATION AND DELIVERY OF SERVICES",
58
+ "44": "8.2 HEALTH AND WELFARE ECONOMICS",
59
+ "45": "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE",
60
+ "46": "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)",
61
+ "47": "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)"
62
+ },
63
+ "initializer_range": 0.02,
64
+ "intermediate_size": 4096,
65
+ "label2id": {
66
+ "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING": 0,
67
+ "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES": 1,
68
+ "1.3 CHEMICAL AND PHYSICAL SCIENCES": 2,
69
+ "1.4 METHODOLOGIES AND MEASUREMENTS": 3,
70
+ "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)": 4,
71
+ "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS": 5,
72
+ "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT": 6,
73
+ "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS": 7,
74
+ "2.4 SURVEILLANCE AND DISTRIBUTION": 8,
75
+ "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)": 9,
76
+ "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)": 10,
77
+ "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING": 11,
78
+ "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS": 12,
79
+ "3.3 NUTRITION AND CHEMOPREVENTION": 13,
80
+ "3.4 VACCINES": 14,
81
+ "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)": 15,
82
+ "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES": 16,
83
+ "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES": 17,
84
+ "4.3 INFLUENCES AND IMPACT": 18,
85
+ "4.4 POPULATION SCREENING": 19,
86
+ "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)": 20,
87
+ "5.1 PHARMACEUTICALS": 21,
88
+ "5.2 CELLULAR AND GENE THERAPIES": 22,
89
+ "5.3 MEDICAL DEVICES": 23,
90
+ "5.4 SURGERY": 24,
91
+ "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 25,
92
+ "5.6 PSYCHOLOGICAL AND BEHAVIOURAL": 26,
93
+ "5.7 PHYSICAL": 27,
94
+ "5.8 COMPLEMENTARY": 28,
95
+ "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)": 29,
96
+ "6.1 PHARMACEUTICALS": 30,
97
+ "6.2 CELLULAR AND GENE THERAPIES": 31,
98
+ "6.3 MEDICAL DEVICES": 32,
99
+ "6.4 SURGERY": 33,
100
+ "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 34,
101
+ "6.6 PSYCHOLOGICAL AND BEHAVIOURAL": 35,
102
+ "6.7 PHYSICAL": 36,
103
+ "6.8 COMPLEMENTARY": 37,
104
+ "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)": 38,
105
+ "7.1 INDIVIDUAL CARE NEEDS": 39,
106
+ "7.2 END OF LIFE CARE": 40,
107
+ "7.3 MANAGEMENT AND DECISION MAKING": 41,
108
+ "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)": 42,
109
+ "8.1 ORGANISATION AND DELIVERY OF SERVICES": 43,
110
+ "8.2 HEALTH AND WELFARE ECONOMICS": 44,
111
+ "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE": 45,
112
+ "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)": 46,
113
+ "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)": 47
114
+ },
115
+ "layer_norm_eps": 1e-12,
116
+ "max_position_embeddings": 512,
117
+ "model_type": "bert",
118
+ "num_attention_heads": 16,
119
+ "num_hidden_layers": 24,
120
+ "output_past": true,
121
+ "pad_token_id": 0,
122
+ "position_embedding_type": "absolute",
123
+ "problem_type": "multi_label_classification",
124
+ "transformers_version": "4.57.0",
125
+ "type_vocab_size": 2,
126
+ "use_cache": true,
127
+ "vocab_size": 30522
128
+ }
metadata.json ADDED
@@ -0,0 +1,204 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ {
2
+ "labels": [
3
+ "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING",
4
+ "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES",
5
+ "1.3 CHEMICAL AND PHYSICAL SCIENCES",
6
+ "1.4 METHODOLOGIES AND MEASUREMENTS",
7
+ "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)",
8
+ "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS",
9
+ "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT",
10
+ "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS",
11
+ "2.4 SURVEILLANCE AND DISTRIBUTION",
12
+ "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)",
13
+ "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)",
14
+ "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING",
15
+ "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS",
16
+ "3.3 NUTRITION AND CHEMOPREVENTION",
17
+ "3.4 VACCINES",
18
+ "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)",
19
+ "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES",
20
+ "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES",
21
+ "4.3 INFLUENCES AND IMPACT",
22
+ "4.4 POPULATION SCREENING",
23
+ "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)",
24
+ "5.1 PHARMACEUTICALS",
25
+ "5.2 CELLULAR AND GENE THERAPIES",
26
+ "5.3 MEDICAL DEVICES",
27
+ "5.4 SURGERY",
28
+ "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
29
+ "5.6 PSYCHOLOGICAL AND BEHAVIOURAL",
30
+ "5.7 PHYSICAL",
31
+ "5.8 COMPLEMENTARY",
32
+ "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)",
33
+ "6.1 PHARMACEUTICALS",
34
+ "6.2 CELLULAR AND GENE THERAPIES",
35
+ "6.3 MEDICAL DEVICES",
36
+ "6.4 SURGERY",
37
+ "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
38
+ "6.6 PSYCHOLOGICAL AND BEHAVIOURAL",
39
+ "6.7 PHYSICAL",
40
+ "6.8 COMPLEMENTARY",
41
+ "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)",
42
+ "7.1 INDIVIDUAL CARE NEEDS",
43
+ "7.2 END OF LIFE CARE",
44
+ "7.3 MANAGEMENT AND DECISION MAKING",
45
+ "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)",
46
+ "8.1 ORGANISATION AND DELIVERY OF SERVICES",
47
+ "8.2 HEALTH AND WELFARE ECONOMICS",
48
+ "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE",
49
+ "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)",
50
+ "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)"
51
+ ],
52
+ "label2id": {
53
+ "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING": 0,
54
+ "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES": 1,
55
+ "1.3 CHEMICAL AND PHYSICAL SCIENCES": 2,
56
+ "1.4 METHODOLOGIES AND MEASUREMENTS": 3,
57
+ "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)": 4,
58
+ "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS": 5,
59
+ "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT": 6,
60
+ "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS": 7,
61
+ "2.4 SURVEILLANCE AND DISTRIBUTION": 8,
62
+ "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)": 9,
63
+ "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)": 10,
64
+ "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING": 11,
65
+ "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS": 12,
66
+ "3.3 NUTRITION AND CHEMOPREVENTION": 13,
67
+ "3.4 VACCINES": 14,
68
+ "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)": 15,
69
+ "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES": 16,
70
+ "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES": 17,
71
+ "4.3 INFLUENCES AND IMPACT": 18,
72
+ "4.4 POPULATION SCREENING": 19,
73
+ "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)": 20,
74
+ "5.1 PHARMACEUTICALS": 21,
75
+ "5.2 CELLULAR AND GENE THERAPIES": 22,
76
+ "5.3 MEDICAL DEVICES": 23,
77
+ "5.4 SURGERY": 24,
78
+ "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 25,
79
+ "5.6 PSYCHOLOGICAL AND BEHAVIOURAL": 26,
80
+ "5.7 PHYSICAL": 27,
81
+ "5.8 COMPLEMENTARY": 28,
82
+ "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)": 29,
83
+ "6.1 PHARMACEUTICALS": 30,
84
+ "6.2 CELLULAR AND GENE THERAPIES": 31,
85
+ "6.3 MEDICAL DEVICES": 32,
86
+ "6.4 SURGERY": 33,
87
+ "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES": 34,
88
+ "6.6 PSYCHOLOGICAL AND BEHAVIOURAL": 35,
89
+ "6.7 PHYSICAL": 36,
90
+ "6.8 COMPLEMENTARY": 37,
91
+ "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)": 38,
92
+ "7.1 INDIVIDUAL CARE NEEDS": 39,
93
+ "7.2 END OF LIFE CARE": 40,
94
+ "7.3 MANAGEMENT AND DECISION MAKING": 41,
95
+ "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)": 42,
96
+ "8.1 ORGANISATION AND DELIVERY OF SERVICES": 43,
97
+ "8.2 HEALTH AND WELFARE ECONOMICS": 44,
98
+ "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE": 45,
99
+ "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)": 46,
100
+ "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)": 47
101
+ },
102
+ "id2label": {
103
+ "0": "1.1 NORMAL BIOLOGICAL DEVELOPMENT AND FUNCTIONING",
104
+ "1": "1.2 PSYCHOLOGICAL AND SOCIOECONOMIC PROCESSES",
105
+ "2": "1.3 CHEMICAL AND PHYSICAL SCIENCES",
106
+ "3": "1.4 METHODOLOGIES AND MEASUREMENTS",
107
+ "4": "1.5 RESOURCES AND INFRASTRUCTURE (UNDERPINNING)",
108
+ "5": "2.1 BIOLOGICAL AND ENDOGENOUS FACTORS",
109
+ "6": "2.2 FACTORS RELATING TO PHYSICAL ENVIRONMENT",
110
+ "7": "2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS",
111
+ "8": "2.4 SURVEILLANCE AND DISTRIBUTION",
112
+ "9": "2.5 RESEARCH DESIGN AND METHODOLOGIES (AETIOLOGY)",
113
+ "10": "2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY)",
114
+ "11": "3.1 PRIMARY PREVENTION INTERVENTIONS TO MODIFY BEHAVIOURS OR PROMOTE WELL-BEING",
115
+ "12": "3.2 INTERVENTIONS TO ALTER PHYSICAL AND BIOLOGICAL ENVIRONMENTAL RISKS",
116
+ "13": "3.3 NUTRITION AND CHEMOPREVENTION",
117
+ "14": "3.4 VACCINES",
118
+ "15": "3.5 RESOURCES AND INFRASTRUCTURE (PREVENTION)",
119
+ "16": "4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES",
120
+ "17": "4.2 EVALUATION OF MARKERS AND TECHNOLOGIES",
121
+ "18": "4.3 INFLUENCES AND IMPACT",
122
+ "19": "4.4 POPULATION SCREENING",
123
+ "20": "4.5 RESOURCES AND INFRASTRUCTURE (DETECTION)",
124
+ "21": "5.1 PHARMACEUTICALS",
125
+ "22": "5.2 CELLULAR AND GENE THERAPIES",
126
+ "23": "5.3 MEDICAL DEVICES",
127
+ "24": "5.4 SURGERY",
128
+ "25": "5.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
129
+ "26": "5.6 PSYCHOLOGICAL AND BEHAVIOURAL",
130
+ "27": "5.7 PHYSICAL",
131
+ "28": "5.8 COMPLEMENTARY",
132
+ "29": "5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)",
133
+ "30": "6.1 PHARMACEUTICALS",
134
+ "31": "6.2 CELLULAR AND GENE THERAPIES",
135
+ "32": "6.3 MEDICAL DEVICES",
136
+ "33": "6.4 SURGERY",
137
+ "34": "6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES",
138
+ "35": "6.6 PSYCHOLOGICAL AND BEHAVIOURAL",
139
+ "36": "6.7 PHYSICAL",
140
+ "37": "6.8 COMPLEMENTARY",
141
+ "38": "6.9 RESOURCES AND INFRASTRUCTURE (TREATMENT EVALUATION)",
142
+ "39": "7.1 INDIVIDUAL CARE NEEDS",
143
+ "40": "7.2 END OF LIFE CARE",
144
+ "41": "7.3 MANAGEMENT AND DECISION MAKING",
145
+ "42": "7.4 RESOURCES AND INFRASTRUCTURE (DISEASE MANAGEMENT)",
146
+ "43": "8.1 ORGANISATION AND DELIVERY OF SERVICES",
147
+ "44": "8.2 HEALTH AND WELFARE ECONOMICS",
148
+ "45": "8.3 POLICY, ETHICS AND RESEARCH GOVERNANCE",
149
+ "46": "8.4 RESEARCH DESIGN AND METHODOLOGIES (HEALTH SERVICES)",
150
+ "47": "8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)"
151
+ },
152
+ "optimal_thresholds": [
153
+ 0.45000000000000007,
154
+ 0.50000000000000013,
155
+ 0.1,
156
+ 0.30000000000000004,
157
+ 0.3500000000000001,
158
+ 0.7500000000000002,
159
+ 0.4500000000000001,
160
+ 0.25000000000000006,
161
+ 0.8000000000000002,
162
+ 0.40000000000000013,
163
+ 0.15000000000000002,
164
+ 0.9000000000000002,
165
+ 0.20000000000000004,
166
+ 0.25000000000000006,
167
+ 0.9000000000000002,
168
+ 0.40000000000000013,
169
+ 0.50000000000000013,
170
+ 0.7500000000000002,
171
+ 0.25000000000000006,
172
+ 0.8500000000000002,
173
+ 0.9000000000000002,
174
+ 0.30000000000000004,
175
+ 0.3500000000000001,
176
+ 0.7500000000000002,
177
+ 0.20000000000000004,
178
+ 0.5500000000000002,
179
+ 0.3500000000000001,
180
+ 0.1,
181
+ 0.5,
182
+ 0.1,
183
+ 0.8000000000000002,
184
+ 0.45000000000000007,
185
+ 0.7000000000000002,
186
+ 0.3500000000000001,
187
+ 0.8000000000000002,
188
+ 0.8000000000000002,
189
+ 0.6500000000000001,
190
+ 0.9000000000000002,
191
+ 0.25000000000000006,
192
+ 0.25000000000000006,
193
+ 0.5500000000000002,
194
+ 0.6000000000000002,
195
+ 0.25000000000000006,
196
+ 0.8000000000000002,
197
+ 0.3500000000000001,
198
+ 0.4000000000000006,
199
+ 0.45000000000000007,
200
+ 0.6500000000000001
201
+ ],
202
+ "base_model_name": "grants_biomedbert",
203
+ "max_len": 512
204
+ }
model.safetensors ADDED
@@ -0,0 +1,3 @@
 
 
 
 
1
+ version https://git-lfs.github.com/spec/v1
2
+ oid sha256:aa7efdea790e03772df8f2911dc66a0e15e3566e51c1243d61489e9fda825861
3
+ size 1340811368
special_tokens_map.json ADDED
@@ -0,0 +1,37 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ {
2
+ "cls_token": {
3
+ "content": "[CLS]",
4
+ "lstrip": false,
5
+ "normalized": false,
6
+ "rstrip": false,
7
+ "single_word": false
8
+ },
9
+ "mask_token": {
10
+ "content": "[MASK]",
11
+ "lstrip": false,
12
+ "normalized": false,
13
+ "rstrip": false,
14
+ "single_word": false
15
+ },
16
+ "pad_token": {
17
+ "content": "[PAD]",
18
+ "lstrip": false,
19
+ "normalized": false,
20
+ "rstrip": false,
21
+ "single_word": false
22
+ },
23
+ "sep_token": {
24
+ "content": "[SEP]",
25
+ "lstrip": false,
26
+ "normalized": false,
27
+ "rstrip": false,
28
+ "single_word": false
29
+ },
30
+ "unk_token": {
31
+ "content": "[UNK]",
32
+ "lstrip": false,
33
+ "normalized": false,
34
+ "rstrip": false,
35
+ "single_word": false
36
+ }
37
+ }
tokenizer.json ADDED
The diff for this file is too large to render. See raw diff
 
tokenizer_config.json ADDED
@@ -0,0 +1,62 @@
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
+ {
2
+ "added_tokens_decoder": {
3
+ "0": {
4
+ "content": "[PAD]",
5
+ "lstrip": false,
6
+ "normalized": false,
7
+ "rstrip": false,
8
+ "single_word": false,
9
+ "special": true
10
+ },
11
+ "1": {
12
+ "content": "[UNK]",
13
+ "lstrip": false,
14
+ "normalized": false,
15
+ "rstrip": false,
16
+ "single_word": false,
17
+ "special": true
18
+ },
19
+ "2": {
20
+ "content": "[CLS]",
21
+ "lstrip": false,
22
+ "normalized": false,
23
+ "rstrip": false,
24
+ "single_word": false,
25
+ "special": true
26
+ },
27
+ "3": {
28
+ "content": "[SEP]",
29
+ "lstrip": false,
30
+ "normalized": false,
31
+ "rstrip": false,
32
+ "single_word": false,
33
+ "special": true
34
+ },
35
+ "4": {
36
+ "content": "[MASK]",
37
+ "lstrip": false,
38
+ "normalized": false,
39
+ "rstrip": false,
40
+ "single_word": false,
41
+ "special": true
42
+ }
43
+ },
44
+ "clean_up_tokenization_spaces": true,
45
+ "cls_token": "[CLS]",
46
+ "do_basic_tokenize": true,
47
+ "do_lower_case": true,
48
+ "extra_special_tokens": {},
49
+ "mask_token": "[MASK]",
50
+ "max_length": 512,
51
+ "model_max_length": 1000000000000000019884624838656,
52
+ "never_split": null,
53
+ "pad_token": "[PAD]",
54
+ "sep_token": "[SEP]",
55
+ "stride": 0,
56
+ "strip_accents": null,
57
+ "tokenize_chinese_chars": true,
58
+ "tokenizer_class": "BertTokenizer",
59
+ "truncation_side": "right",
60
+ "truncation_strategy": "longest_first",
61
+ "unk_token": "[UNK]"
62
+ }
vocab.txt ADDED
The diff for this file is too large to render. See raw diff